Liberum Capital lowered shares of Spire Healthcare Group PLC (LON:SPI) to a hold rating in a research note issued to investors on Wednesday, July 19th. They currently have GBX 370 ($4.82) target price on the stock, down from their prior target price of GBX 400 ($5.21).
Other analysts also recently issued reports about the stock. Berenberg Bank reissued a buy rating and issued a GBX 360 ($4.69) price target on shares of Spire Healthcare Group PLC in a research note on Wednesday, April 12th. Jefferies Group LLC boosted their price target on shares of Spire Healthcare Group PLC from GBX 305 ($3.97) to GBX 350 ($4.56) and gave the stock a hold rating in a research note on Thursday, June 1st. Finally, Numis Securities Ltd reissued an add rating and issued a GBX 370 ($4.82) price target on shares of Spire Healthcare Group PLC in a research note on Tuesday, April 4th. One analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company. The company has an average rating of Hold and a consensus target price of GBX 361.63 ($4.71).
Spire Healthcare Group PLC (LON SPI) traded down 0.81% on Wednesday, reaching GBX 330.90. The company’s stock had a trading volume of 402,323 shares. The stock’s 50 day moving average price is GBX 337.81 and its 200 day moving average price is GBX 333.23. The company’s market cap is GBX 1.32 billion. Spire Healthcare Group PLC has a 12 month low of GBX 297.50 and a 12 month high of GBX 411.00.
COPYRIGHT VIOLATION WARNING: “Spire Healthcare Group PLC (LON:SPI) Stock Rating Lowered by Liberum Capital” was originally posted by BNB Daily and is the property of of BNB Daily. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.baseball-news-blog.com/2017/08/13/spire-healthcare-group-plc-lonspi-stock-rating-lowered-by-liberum-capital-updated-updated-updated.html.
About Spire Healthcare Group PLC
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.